Navigation Links
CompareNetworks, Inc. Fuels Growth by Raising Round of Financing
Date:4/1/2008

SOUTH SAN FRANCISCO, Calif., April 1, 2008 /PRNewswire/ -- CompareNetworks, Inc., a global online B2B media company for the life science and healthcare industries, today announced that it has closed a round of financing from Alta Communications.

Based in South San Francisco, California, CompareNetworks operates vertical websites and email newsletters that target life science researchers, medical and dental professionals. The CompareNetworks sites, which include biocompare.com, medcompare.com, dentalcompare.com and ophthalmologyweb.com, help marketers in their respective industries target decision makers in these specialized fields. CompareNetworks generates highly qualified sales leads through its comprehensive marketplaces, targeted editorial and video content.

Today's announcement follows a strong growth year for CompareNetworks. "We couldn't be happier with the results we have achieved," said Paul Gatti, CEO of CompareNetworks. "Our growth leaves us confident in the reputation we have earned for ourselves in the communities and advertisers we service. Our partnership with Alta Communications will allow us to accelerate growth in 2008 and beyond. We look forward to being the driving force in new media for these markets and others."

CompareNetworks has had significant revenue growth over the past 3 years and now has over 400 recurring customers. Additionally, CompareNetworks continues to expand its services with more user-driven content, specialized search tools, and online multimedia education.

"We are excited to be working with the CompareNetworks team," said Timothy Dibble, managing partner at Alta Communications, "The trend of ad dollars moving online will continue for the foreseeable future and CompareNetworks is in the perfect place to benefit."

CompareNetworks, Inc.

Headquartered in South San Francisco, California, CompareNetworks is a leading media company for the life science and healthcare industries. The C
'/>"/>

SOURCE CompareNetworks, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Researchers identify and shut down protein that fuels ovarian cancer
2. NexGen Biofuels Ltd Announces the Change of its Symbol to "NXGN"
3. Medicare Drug Plan Fuels Health-Care Spending
4. OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
5. Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
7. Study fuels debate over whether exercise and body size influence ovarian cancer risk
8. Plastic Surgery Procedures Maintain Steady Growth in 2007
9. SPO Medical Reports 2007 Sales: Growth of 35% Compared to 2006
10. Perrigo Company to Present at the 12th Annual Sidoti Emerging Growth Institutional Investor Forum
11. DuPont Chief Financial Officer Reviews Companys Accelerated Growth Plan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...ivors of testicular cancer who were treated with c...ffects, including neurological side effects and Ra...d with chemotherapy, according to a new study publ...tional Cancer Institute . , Marianne Brydy, M.D....ity Hospital, in Bergen, Norway, and colleagues co...
(Date:11/25/2009)... discovery that grew out of a collaboration betwee...offer hope to the nearly 10 million Americans who ...lso known as hardening of the arteries, peripheral... problem in which narrowed arteries reduce blood f...d flag for vascular disease, heart attack and stro...
(Date:11/25/2009)...-up period was too short to draw definite conclusi...5 (HealthDay News) -- In diabetic patients with bl...fference in outcomes at one year whether patients ...g, British researchers report. , Bypass surgery...ents with coronary artery disease. However, less i...
(Date:11/25/2009)... Evaluation and treatment clinics to resu...stock (Vocus) November 25, 2009 -- Centegra Health... and H1N1 vaccine shots at four Centegra Primary C...nt of vaccine has arrived. The clinics are at CPC ...nry and will be open as follows: ,   F...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... BARCELONA, SPAIN, September 25, 2007 In clinica...lung cancer (NSCLC) that are classified as having ...nificant higher survival when treated in the secon...t # 6521) were presented at the 14th European Can...
...tient received stolen piece of bone during neck su...exas man has filed a,lawsuit against the billion-d...YSE: MDT ) for fraud and negligence in a "body-sn...eme Court of the State of New York also names as d...
...W YORK, Sept. 26 The American Liver Foundation (A...search and improving the,quality of life for the 3...today that Rick Smith has been named to become the...ience leading prominent,national health organizati...
... Barcelona, Spain: In a surprising finding, Americ...ageal cancer, married patients dont fare as well a...their quality of life. , In the study, presented..., a non-cancerous condition linked to acid reflux,...
...USTON, Sept. 26 US Med-Equip, an industry leader ...rvice and smarts to acute,care and homecare provid...Houston, Texas. This expansion into a state of the...on it for future,plans. The 15,000 square feet of ...
...S ANGELES, Sept. 26 TIGroup, Inc. (OTC,Bulletin B...s provider to,the healthcare industry focused on a...sses designed to deliver quality healthcare servic...company,s board,since 2001. Smith was most recent...
Other Medicine News:Health News:Studies suggest key correlation between lung cancer subtype and treatment outcomes 2Health News:Studies suggest key correlation between lung cancer subtype and treatment outcomes 3Health News:The Law Offices of John David Hart: Texas Man Sues Medtronic in 'Body-Snatching' Case 2Health News:The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer 2Health News:Married esophageal cancer patients fare worse in some quality of life aspects than single patients 2Health News:US Med-Equip Expands Corporate Support Center 2Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 2Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 3Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 4
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResear...: Stelara report,thefirstinamulti-phasesyndicate...rtho-Biotech,sStelara,fromproductlaunchthroughthef...videsquantitativeinformationfrom75uniqueDermatolog...portsassesstrialanduseofStelara,obstaclestouse,typ...
(Date:11/25/2009)..., WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCal...,especiallythe27millionlivingwithuntreated hearing...istCindyBeyer. ,, Dr.Beyer,seniorvicepresidento...areand hearingaids companies,saidstudieshavelinked...,"whichcaneasilybeintensifiedatholidaygatheringswi...
(Date:11/25/2009)..., RANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPA...cCorporation(Nasdaq: APFC )announcedtodaythatitrec...tyAwardattheAnnualStatewideEnvironmentalSummit,spo...ociation(CMTA),theIndustrialEnvironmentalAssociati...ICC)heldinSanDiego.Thisisthemostprestigiousawardav...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Baking Soda May Be Key Ingredient for Kidney Patients 52007 1Baking Soda May Be Key Ingredient for Kidney Patients 52007 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 1Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 4Wake Forest Baptist Medical Center Names Chadwick CFO 51998 1Wake Forest Baptist Medical Center Names Chadwick CFO 51998 2
...DA Submission in 2009, SEATTLE, March 25 Cell Th...nced today that enrollment is complete in,the phas... (BBR2278) for,patients with relapsed diffuse larg... of the data is expected in the second half of 200...nd Drug Administration (FDA) the data,could provid...
...if., March 24 NuRx,Pharmaceuticals, Inc. (OTC Bul...e first patient in a Phase I clinical trial of the...X4204., The single-center study, which NuRx expec... is designed to evaluate the safety and tolerabili... drug candidate in clinical,trials., "Our preclin...
Other Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2
Schuco® 3000 Nebulizer
... developing diverse medical products for more than...ed an outstanding reputation for innovation, quali...ationally recognized brands include the Labtron&re...ical sundry products, Bristoline® microscopes,...
...ntrainment Nebulizers deliver particulate humidity...tion patients. For your convenience, Thera-Mist&re...y of sterile water., ,The P30000N, for normal flo...tal flow range of 68-24 lpm. For your high flow ne...
...er can be held at angles up to 45° without sac...mn, finger grooves for a non-slip gripping surface... of regular oxygen tubing. The large diffuser and...tain optimum mist concentration at every setting. ...
Medicine Products: